FDA reviews safety of children's cold medicines

NEW YORK - U.S. health regulators said Friday they have been reviewing the safety of over-the-counter children’s cough and cold medications, especially for those under age 2.

“We have been looking at this issue internally with regard to the safety and efficacy of cough, cold products in children,” said Dr. Charles Ganley, head of the Food and Drug Administration’s Office of Nonprescription Products. 

The FDA said it could not yet determine whether new regulations would result from the safety review, according to a report in the New York Times Friday.

A group of pediatricians and public health officials asked the agency Thursday to bar drug manufacturers from marketing such remedies as Toddler’s Dimetapp, Infant Triaminic and Little Colds to children under 6.

A recent study by the federal Centers for Disease Control and Prevention showed that more than 1,500 children under 2 had experienced serious health problems — and three died — after taking common cold medicines in 2004 and 2005. The American College of Chest Physicians last year recommended avoiding using cough and cold medicines in children, especially young ones.

INTERACTIVE Test your IQ Is it a cold, the flu or something else?

In above-normal doses, cold medicines can lead to heart arrhythmias, and some have been linked to hypertension and stroke when taken in high doses, The Times reported. In rare cases, children have had medical problems after taking recommended doses, the article said.

The president of the Consumer Healthcare Products Association, which represents companies that sell over-the-counter cold drugs, noted that the medicines had FDA approval and had been used for decades. They should be taken only in recommended doses, association president Linda A. Suydam said.

The pediatricians who petitioned the FDA Thursday acknowledged that children’s cold medicines were generally safe in recommended doses, but they said overdoses were common because many children were given more than one medicine, among other reasons. They also questioned the drugs’ effectiveness in children.

Many cold and cough drugs won FDA approval decades ago, when the agency’s standards were less strict, The Times reported.

MORE FROM KIDS AND PARENTING

Kids and parenting Section Front

Lead, dangerous chemicals found in toys CPSC chief: Agency moved too slowly on crib safety Largest crib recall in U.S. history announced Kids watching hours of TV at home daycare Biggest child-killers: pneumonia and diarrhea 1 formerly conjoined twin talking after surgery FDA panel OKs new kids’ pneumococcal shot Toxic toys? Health group finds high lead levels Sex infections still rising, especially in teens FDA weighs updated kids’ pneumococcal shot Kids and parenting Section Front   Add Kids and parenting headlines to your news reader: